Although the amyloid cascade hypothesis postulates that Aβ is the initiator of the pathological cascade of AD [9], very recent meta-analyses of pathophysiological biomarkers of AD suggest that Aβ and tau may be partly independent of each other and interact synergistically [13,5]. The gene discussed is MAPT; the disease is Alzheimer disease.